August 24, 2026
Adovate Partners with CvilleBioHub, VEDP, and the University of Virginia to Develop Virginia’s Next Generation of Biotechnology Talent
Charlottesville, VA – August 24, 2026 – Adovate, LLC (“Adovate” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics targeting the adenosine receptors, today announced the successful completion of its 2026 summer internship initiative